Greene calls for yanking FDA approval of COVID-19 vaccines: 'Causing permanent harm and deaths'
Rep. Marjorie Taylor Greene calls for yanking FDA approval of COVID-19 vaccines, says that "COVID-19 vaccines are causing ...
MedPage Today on MSN1d
Vutrisiran Snags FDA Approval for TTR Amyloidosis Cardiomyopathy
Gene-silencing therapy vutrisiran (Amvuttra) graduated to a broad indication in treatment of transthyretin amyloidosis ...
The American Journal of Managed Care1d
FDA Approves Oral Iptacopan for C3 Glomerulopathy
The FDA approved oral iptacopan (Fabhalta; Novartis) to reduce proteinuria in adults with C3 glomerulopathy (C3G), according ...
FDA approves first non-opioid pain treatment in two decades, providing new hope
Each year, millions of people in America are prescribed a medicine for acute pain.Now, for the first time in over 20 years, ...
BioSpace1d
Novartis’ Fabhalta Approved as First Therapy for Rare Kidney Disease
This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal ...
Fewer than half of Medicaid managed care plans provide all FDA-approved medications for alcohol use disorder
As health complications and deaths from alcohol use disorder (AUD) increase in the United States, it is critical that people ...
Telix Pharmaceuticals Gets FDA Approval for Prostate Cancer Screening Agent
Key Takeaways Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for ...
Fierce Pharma1d
Alnylam's Amvuttra wins key approval in ATTR-CM, teeing up showdown with Pfizer
Despite growing competition in the transthyretin amyloid cardiomyopathy (ATTR-CM) field, Alnylam is hoping its RNA ...